Pioneering breakthrough in the chemical synthesis of Interferon β-1a

July 10, 2013
Bachem building at the Bubendorf manufacturing site

Bubendorf/Basel, Switzerland and Kyoto, Japan, July 10, 2013 – GlyTech, Inc. (Kyoto, Japan) and Bachem AG (Bubendorf, Switzerland) informed that they have successfully co-developed a chemical synthesis of Interferon β-1a for industrial scale.